Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Predictive Value of Rapid Shallow Breathing Index (RSBI) and CRP-Albumin-Lymphocyte (CALLY) Indices in Predicting the Success of Weaning From Mechanical Ventilation in Intensive Care Patients: A Prospective Observational Study

NCT07571317 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

NCT NCT07571317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07571317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Predictive Value of Rapid Shallow Breathing Index (RSBI) and CRP-Albumin-Lymphocyte (CALLY) Indices in Predicting the Success of Weaning From Mechanical Ventilation in Intensive Care Patients: A Prospective Observational Study
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Observational
Overall status
Recruiting
Start date
May 4, 2026
Completion date
July 31, 2026
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, respiratory insufficiency, ventilator weaning, weaning failure of mechanical ventilation